Asia Pacific Heart Transplant Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030

Analysis - by Surgery Type (Orthotopic Heart Transplant and Heterotopic Heart Transplant), Type (Donor Live Heart and Artificial Hearts), and End User (Hospitals, Cardiac Centers, and Others)


No. of Pages: 70    |    Report Code: BMIRE00030079    |    Category: Life Sciences

Asia Pacific Heart Transplant Market
Buy Now

The Asia Pacific heart transplant market is expected to grow from US$ 3,425.68 million in 2022 to US$ 7,739.74 million by 2030. It is estimated to grow at a CAGR of 10.7% from 2022 to 2030. 

Growing Geriatric Population Boosts Asia Pacific Heart Transplant Market

The geriatric population is prone to CVDs, orthopedic disorders, metabolic disorders, and neurological disorders, among others. According to the WHO, the aging population across the world is likely to rise from ~1 billion in 2019 to ~2.1 billion by 2050. With China and India accounting for more than one billion people each, Asia's population surpassed 4.5 billion as of 2020, making up more than half of the world's total population. Asians were predicted to number 414 million, which is around 20% more than the 331.4 million Americans who are 65 years of age or older. By 2050, it is expected that Asia will have over 923 million elderly population. Hence, the growing elderly population, along with the increasing prevalence of heart failure, fuels the heart transplant market growth.

Asia Pacific Heart Transplant Market Overview

The Asia Pacific heart transplant market is segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia Pacific. Asia Pacific is expected to register the fastest CAGR in the global market during the forecast period. The market growth in this region is ascribed to the rise in healthcare awareness of the importance of organ donation and a surge in social media marketing to encourage a positive attitude toward organ donation. Additionally, advancing healthcare infrastructure and increasing investments to boost manufacturing capacities are projected to drive the Asia Pacific heart transplant market during the forecast period. According to an article published in BioMed Central, more than 40% of the deaths in China are attributed to CVDs. In addition, in 2019, about 120.33 million people suffered from CVDs in China. Rapid socioeconomic progress is impacting the lifestyle of the population in China, which, in turn, increases the chances of contracting CVDs, conditions of heart or blood vessels that may result in heart failure. At present, heart transplantation is the only well-known effective treatment for advanced heart failure. However, owing to the limited number of heart donors, only ~300 heart transplants are performed in China annually. Therefore, people suffering from heart failure opt for artificial heart transplants due to the long waiting list for heart transplantation.

Asia Pacific Heart Transplant Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Heart Transplant Market Revenue and Forecast to 2030 (US$ Million)
Get more information on this report

Asia Pacific Heart Transplant Strategic Insights

Strategic insights for the Asia Pacific Heart Transplant provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/asia-pacific-heart-transplant-market-strategic-framework.webp
Get more information on this report

Asia Pacific Heart Transplant Report Scope

Report Attribute Details
Market size in 2022 US$ 3,425.68 Million
Market Size by 2030 US$ 7,739.74 Million
Global CAGR (2022 - 2030) 10.7%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By Surgery Type
  • Orthotopic Heart Transplant and Heterotopic Heart Transplant
By Type
  • Donor Live Heart and Artificial Hearts
By End User
  • Hospitals
  • Cardiac Centers
Regions and Countries Covered Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
Market leaders and key company profiles
  • Terumo Corp
  • Abbott Laboratories
  • SynCardia Systems LLC
  • BiVACOR Inc
  • BioVentrix Inc
  • LivaNova Plc
  • Get more information on this report

    Asia Pacific Heart Transplant Regional Insights

    The geographic scope of the Asia Pacific Heart Transplant refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/asia-pacific-heart-transplant-market-geography.webp
    Get more information on this report

    Asia Pacific Heart Transplant Market Segmentation

     

    The Asia Pacific heart transplant market is segmented into surgery type, type, end user, and country. 

    Based on surgery type, the Asia Pacific heart transplant market is bifurcated into orthotopic heart transplantation and heterotopic heart transplantation. The orthotopic heart transplantation segment held a larger share of the Asia Pacific heart transplant market in 2022.

    In terms of type, the Asia Pacific heart transplant market is bifurcated into donor live heart and artificial heart. The donor live heart segment held a larger share of the Asia Pacific heart transplant market in 2022. Further, artificial heart segment is categorized into ventricular assisted device and total artificial heart.

    Based on end user, the Asia Pacific heart transplant market is segmented into hospitals, cardiac centres, and others. The hospitals segment held the largest share of the Asia Pacific heart transplant market in 2022. 

    Based on country, the Asia Pacific heart transplant market is segmented into China, India, South Korea, Japan, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific heart transplant market in 2022. 

    Terumo Corp, Abbott Laboratories, SynCardia Systems LLC, BiVACOR Inc, BioVentrix Inc, and LivaNova Plc are some of the leading companies operating in the Asia Pacific heart transplant market. 

    The List of Companies - Asia Pacific Heart Transplant Market

    1. Terumo Corp

     

    2. Abbott Laboratories

    3. SynCardia Systems LLC

    4. BiVACOR Inc

    5. BioVentrix Inc

    6. LivaNova Plc

     

    Frequently Asked Questions
    How big is the Asia Pacific Heart Transplant Market?

    The Asia Pacific Heart Transplant Market is valued at US$ 3,425.68 Million in 2022, it is projected to reach US$ 7,739.74 Million by 2030.

    What is the CAGR for Asia Pacific Heart Transplant Market by (2022 - 2030)?

    As per our report Asia Pacific Heart Transplant Market, the market size is valued at US$ 3,425.68 Million in 2022, projecting it to reach US$ 7,739.74 Million by 2030. This translates to a CAGR of approximately 10.7% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Heart Transplant Market report typically cover these key segments-

    • Surgery Type (Orthotopic Heart Transplant and Heterotopic Heart Transplant)
    • Type (Donor Live Heart and Artificial Hearts)
    • End User (Hospitals, Cardiac Centers)

    What is the historic period, base year, and forecast period taken for Asia Pacific Heart Transplant Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Heart Transplant Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in Asia Pacific Heart Transplant Market?

    The Asia Pacific Heart Transplant Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Terumo Corp
  • Abbott Laboratories
  • SynCardia Systems LLC
  • BiVACOR Inc
  • BioVentrix Inc
  • LivaNova Plc
  • Who should buy this report?

    The Asia Pacific Heart Transplant Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Heart Transplant Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now